In France until the end of 2015, oocyte donors must have had at least one child and be aged
18–37 years. This population of fertile women was selected to examine whether serum anti …

BACKGROUND Anti-Müllerian hormone (AMH) levels are used to evaluate the ovarian
reserve. AMH serum concentrations have recently been studied among women attending …

Objectives To investigate the association between anti-Müllerian hormone (AMH), a well-
established marker of the ovarian reserve, and time-to-pregnancy (TTP) in natural …

The objectives of this study were to investigate whether anti-Müllerian hormone (AMH)
concentrations can predict pregnancy rates and time to pregnancy (TTP) in women …

The conflicting results from studies on the predictive capabilities of serum anti-Müllerian
hormone (AMH) for IVF pregnancy outcomes may be attributed to small sample sizes and …

Purpose The aim of this study was to investigate the relevance of serum and follicular anti-
Müllerian hormone (AMH) concentrations on ovarian reserve and clinical pregnancy …

OBJECTIVES: The assessment of the ovarian reserve is mandatory in women undergoing
assisted reproduction. Antimüllerian hormone (AMH) produced by granulosa cells from …

Objective This study aimed to identify a possible correlation between serum levels of anti-
Müllerian hormone (AMH) and oocyte quality, embryo developmental competence, and …

Introduction The correlation between ovarian reserve and infertility remains unclear. Albeit
poorly predictive of pregnancy success in in vitro fertilization cycles, serum anti‐Müllerian …

Objectives The aim was to evaluate the association between serum Anti-Müllerian Hormone
(AMH) level and cumulative live birth rates (LBR) in patients undergoing their first in vitro …